Most employer plans allow coverage for GLP1 drugs when prescribed for diabetes, but only a few employers cover GLP1s for weight loss, often with restrictions like body mass index (BMI) thresholds or lifestyle program participation
For researchers building a comprehensive IGF axis research workflow, the standard approach is to use IGF-1 LR3 as the primary tool for sustained IGF1R activation studies, native IGF-1 for short-pulse studies where IGFBP biology is itself the research question, and DES IGF-1 for the narrow set of experiments requiring receptor activation with rapid washout
Mori, S
The decision is individualized: Pregnancy, breastfeeding, or planning pregnancy within the next two months
Coverage for the newer, more effective GLP-1 agoniststhe ones making all the headlines like Wegovy (Semaglutide) and Zepbound (Tirzepatide)is much rarer and comes with far more stringent requirements
When taking tirzepatide, two significant processes occur: GLP-1 activation signals fullness faster, while GIP activation enhances sugar processing and insulin regulation